[Clinical use of the interaction between cyclosporine A and its inhibitors].
This article concerns cyclosporine A and cyclosporine--sparing agents. The drugs are evaluated due to their clinical usefulness in elevating cyclosporine blood level and their safety in long-term administration. We analyzed imidazole antifungal agents, calcium channel blockers and, additionally, pharmacological properties of cyclosporine A.
Szaliński
Marek
M
Katedra i Klinika Okulistyki Akademii Medycznej we Wrocławiu. marekmed@fa.am.wroc.pl
Magdalan
Jan
J
Misiuk-Hojło
Marta
M
Słowik
Mirosław
M
D000935:Antifungal Agents / Q000037:antagonists & inhibitors*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D016572:Cyclosporine / Q000037:antagonists & inhibitors* / Q000097:blood; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects
D000935:Antifungal Agents; D002121:Calcium Channel Blockers; D004791:Enzyme Inhibitors; D007093:Imidazoles; C029899:imidazole; D016572:Cyclosporine